Published in J Immunol on July 01, 1996
Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor. J Immunother (2009) 2.35
Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness. J Exp Med (1997) 1.44
Sequence, structure, function, immunity: structural genomics of costimulation. Immunol Rev (2009) 1.08
Crystal structure of the receptor-binding domain of human B7-2: insights into organization and signaling. Proc Natl Acad Sci U S A (2003) 1.06
PKC-theta-mediated signal delivery from the TCR/CD28 surface receptors. Front Immunol (2012) 0.97
Mechanisms of monophosphoryl lipid A augmentation of host responses to recombinant HagB from Porphyromonas gingivalis. Infect Immun (2002) 0.92
Cytotoxic T lymphocyte antigen 4 is induced in the thymus upon in vivo activation and its blockade prevents anti-CD3-mediated depletion of thymocytes. J Exp Med (1998) 0.90
Construction and characterization of a triple-recombinant vaccinia virus encoding B7-1, interleukin 12, and a model tumor antigen. J Natl Cancer Inst (1998) 0.85
The modulation of B7.2 and B7.1 on B cells by immunosuppressive agents. Clin Exp Immunol (1999) 0.82
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature (1998) 24.69
The antigenic structure of the HIV gp120 envelope glycoprotein. Nature (1998) 12.44
A soluble form of CD4 (T4) protein inhibits AIDS virus infection. Nature (1988) 6.39
Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates. Structure (2000) 5.57
Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature (1985) 5.06
Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature (1990) 4.81
The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activity. Nature (1984) 4.61
Energetics of the HIV gp120-CD4 binding reaction. Proc Natl Acad Sci U S A (2000) 4.44
Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120. Proc Natl Acad Sci U S A (1991) 4.40
Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells. Cell (1984) 3.81
Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. Nature (1989) 3.54
Probability analysis of variational crystallization and its application to gp120, the exterior envelope glycoprotein of type 1 human immunodeficiency virus (HIV-1). J Biol Chem (1999) 2.85
Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling. Nature (1994) 2.63
Envelope glycoproteins from biologically diverse isolates of immunodeficiency viruses have widely different affinities for CD4. Proc Natl Acad Sci U S A (1991) 2.54
A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J Biol Chem (1997) 2.00
Purification and characterization of human H-ras proteins expressed in Escherichia coli. Mol Cell Biol (1985) 1.77
Structural analysis of the human immunodeficiency virus-binding domain of CD4. Epitope mapping with site-directed mutants and anti-idiotypes. J Exp Med (1989) 1.60
Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth. J Biol Chem (1998) 1.60
Comparison of some reactions catalyzed by deoxyribonucleic acid polymerase from avian myeloblastosis virus, Escherichia coli, and Micrococcus luteus. Biochemistry (1972) 1.58
Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle. J Virol (2000) 1.57
Murine mammary tumor virus pol-related sequences in human DNA: characterization and sequence comparison with the complete murine mammary tumor virus pol gene. J Virol (1986) 1.57
Role of intra- and extracellular calcium in histamine release from rat peritoneal mast cells. Agents Actions (1981) 1.53
Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT down-regulates its own receptor. J Immunol (2000) 1.42
The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity. J Immunol (2001) 1.31
The structure of the thymidine kinase gene promoter: nuclease hypersensitivity correlates with expression. Cell (1982) 1.30
Calcium pools involved in histamine release from rat mast cells. Int Arch Allergy Appl Immunol (1980) 1.30
Major histocompatibility complex class I molecules internalized via coated pits in T lymphocytes. Nature (1987) 1.28
Human immunodeficiency virus type 2 envelope glycoprotein: differential CD4 interactions of soluble gp120 versus the assembled envelope complex. Virology (1992) 1.28
Elimination of Fc receptor-dependent effector functions of a modified IgG4 monoclonal antibody to human CD4. J Immunol (2000) 1.23
Effect of human immunodeficiency virus gp120 glycoprotein on the association of the protein tyrosine kinase p56lck with CD4 in human T lymphocytes. J Biol Chem (1991) 1.19
The presence of unique DNA sequences after viral induction of leukemia in mice. (RNA tumor virus-nucleic acid hybridization-insertion of viral DNA). Proc Natl Acad Sci U S A (1974) 1.19
Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines. J Immunol (1998) 1.18
Inhibition of histamine secretion from mast cells. Nature (1981) 1.17
Gene transactivation mediated by the TAT gene of human immunodeficiency virus in transgenic mice. Nucleic Acids Res (1988) 1.15
Induction of interleukin 2 receptor (TAC) by tumor necrosis factor in YT cells. J Immunol (1987) 1.11
The role of p21ras in CD28 signal transduction: triggering of CD28 with antibodies, but not the ligand B7-1, activates p21ras. J Exp Med (1994) 1.09
Oligodeoxynucleotides interact with recombinant CD4 at multiple sites. J Biol Chem (1993) 1.08
Two receptors are required for antibody-dependent enhancement of human immunodeficiency virus type 1 infection: CD4 and Fc gamma R. J Virol (1990) 1.08
Kinetic and structural analysis of mutant CD4 receptors that are defective in HIV gp120 binding. Proc Natl Acad Sci U S A (1996) 1.07
Characterization of CD4-gp120 activation intermediates during human immunodeficiency virus type 1 syncytium formation. AIDS Res Hum Retroviruses (1996) 1.07
Distinction between antigen receptor and IL 2 receptor triggering events in the activation of alloreactive T cell clones with calcium ionophore and phorbol ester. J Immunol (1985) 1.06
Structures of an HIV and MHC binding fragment from human CD4 as refined in two crystal lattices. Structure (1994) 1.03
Characterisation of a virus (HL23V) isolated from cultured acute myelogenous leukaemic cells. Nature (1976) 1.01
Bicyclic imidazoles as a novel class of cytokine biosynthesis inhibitors. Ann N Y Acad Sci (1993) 1.01
Molecular characteristics of recombinant human CD4 as deduced from polymorphic crystals. Proc Natl Acad Sci U S A (1990) 1.01
Stimulation of non-Hodgkin's lymphoma via HVEM: an alternate and safe way to increase Fas-induced apoptosis and improve tumor immunogenicity. Leukemia (2003) 1.01
Protein and carbohydrate structural analysis of a recombinant soluble CD4 receptor by mass spectrometry. J Biol Chem (1989) 1.00
CD4: its structure, role in immune function and AIDS pathogenesis, and potential as a pharmacological target. Curr Opin Biotechnol (1991) 0.99
Signal transduction by CD28 costimulatory receptor on T cells. B7-1 and B7-2 regulation of tyrosine kinase adaptor molecules. J Biol Chem (1996) 0.99
Repeated administration of adenoviral vectors in lungs of human CD4 transgenic mice treated with a nondepleting CD4 antibody. J Immunol (1999) 0.98
Identification of residues in the V domain of CD80 (B7-1) implicated in functional interactions with CD28 and CTLA4. J Exp Med (1995) 0.97
Somatic DNA rearrangement generates functional rat immunoglobulin kappa chain genes: the J kappa gene cluster is longer in rat than in mouse. Gene (1982) 0.97
Inhibition of histamine release from rat peritoneal mast cells treated with the ionophore A23187. Implications for the mode of action of anti-allergic compounds. Agents Actions (1981) 0.96
Purification and characterization of the DNA polymerase of human breast cancer particles. Proc Natl Acad Sci U S A (1977) 0.95
Nucleic acid sequence relationships among "slow" viruses of sheep. Virology (1976) 0.94
Modification of the Fc region of a primatized IgG antibody to human CD4 retains its ability to modulate CD4 receptors but does not deplete CD4(+) T cells in chimpanzees. Clin Immunol (2001) 0.94
Two distinct intracytoplasmic regions of the T-cell adhesion molecule CD28 participate in phosphatidylinositol 3-kinase association. J Biol Chem (1996) 0.93
Endocytosis and de novo expression of major histocompatibility complex encoded class I molecules: kinetic and ultrastructural studies. Eur J Cell Biol (1987) 0.92
A highly selected panel of anti-CD4 antibodies fails to induce anti-idiotypic antisera mediating human immunodeficiency virus neutralization. Eur J Immunol (1991) 0.91
Viral-related DNA sequences before and after transformation by RNA tumor viruses. Int J Cancer (1973) 0.91
Characteristics of and calcium requirements for histamine release from rat peritoneal mast cells treated with concanavalin A. Int Arch Allergy Appl Immunol (1981) 0.89
Calcium ionophore plus phorbol ester can substitute for antigen in the induction of cytolytic T lymphocytes from specifically primed precursors. J Immunol (1985) 0.89
Weak acid-induced release of liposome-encapsulated carboxyfluorescein. Biochim Biophys Acta (1984) 0.87
Immunization with soluble murine CD4 induces an anti-self antibody response without causing impairment of immune function. J Immunol (1991) 0.86
A primatized MAb to human CD4 causes receptor modulation, without marked reduction in CD4+ T cells in chimpanzees: in vitro and in vivo characterization of a MAb (IDEC-CE9.1) to human CD4. Clin Immunol Immunopathol (1997) 0.86
Endocytosis of liposomes bound to cell surface proteins measured by flow cytofluorometry. Biochem J (1983) 0.86
Immunological cross-reactions of the major internal protein component from "slow" viruses of sheep. Virology (1977) 0.86
Preclinical development of keliximab, a Primatized anti-CD4 monoclonal antibody, in human CD4 transgenic mice: characterization of the model and safety studies. Hum Exp Toxicol (2000) 0.85
Recent duplication and germ-line diversification of rat immunoglobulin kappa chain gene joining segments. Proc Natl Acad Sci U S A (1982) 0.85
Isolation of a neutralizing human RSV antibody from a dominant, non-neutralizing immune repertoire by epitope-blocked panning. J Immunol (1996) 0.85
The genetic analysis of the HIV envelope binding domain on CD4. Ann N Y Acad Sci (1990) 0.84
Measurement of protein interaction bioenergetics: application to structural variants of anti-sCD4 antibody. Methods Enzymol (2000) 0.83
Role of cyclic AMP in the induction of histamine secretion from mast cells. Agents Actions (1985) 0.82
Microinjection of the ras oncogene protein into nonestablished rat embryo fibroblasts. Cancer Res (1986) 0.82
Effect of anti-allergic compounds on histamine release from rat peritoneal mast cells treated with concanavalin A. Int Arch Allergy Appl Immunol (1981) 0.82
Down-regulation of beta-adrenergic receptors by pindolol in Gs alpha-transfected S49 cyc- murine lymphoma cells. J Neurochem (1992) 0.82
Comparison of CD28-B7.1 and B7.2 functional interaction in resting human T cells: phosphatidylinositol 3-kinase association to CD28 and cytokine production. Eur J Immunol (1996) 0.82
Antibody-bearing liposomes as multicolor immunofluorescence markers for flow cytometry and imaging. J Immunol Methods (1987) 0.82
CD28 signal transduction pathways. A comparison of B7-1 and B7-2 regulation of the map kinases: ERK2 and Jun kinases. Mol Immunol (1996) 0.82
Functional human CD4 protein produced in milk of transgenic mice. Mol Biol Med (1989) 0.82
Inhibition of contact sensitivity in human CD4+ transgenic mice by human CD4-specific monoclonal antibodies: CD4+ T-cell depletion is not required. Immunology (2000) 0.81
Pyridinyl imidazoles inhibit the inflammatory phase of delayed type hypersensitivity reactions without affecting T-dependent immune responses. Int J Immunopharmacol (1994) 0.81
Structural features of CD4 required for binding to HIV. J Immunol (1989) 0.81
Interdomain communication of T-cell CD4 studied by absorbance and fluorescence difference spectroscopy measurements of urea-induced unfolding. Biochemistry (1995) 0.80
An efficient phage plaque screen for the random mutational analysis of the interaction of HIV-1 gp120 with human CD4. J Biol Chem (1992) 0.80
DHFR coamplification of t-PA in DHFR+ bovine endothelial cells: in vitro characterization of the purified serine protease. DNA (1988) 0.80
Lectin-induced histamine secretion from isolated rat and guinea pig mast cells. Biochem Pharmacol (1981) 0.78
Lymphocyte function-associated antigens one (LFA-1) on B and on T lymphocytes bind a monoclonal antibody with different affinities. Cell Immunol (1985) 0.78
Functional expression of human CD28 in murine T cell hybridomas. Mol Immunol (1994) 0.77